SFRP2 and neoplasm: To test if these markers could serve as prognostic biomarkers already in primary tumours survival analysis was performed in a large cohort of 504 patients with primary HGSOC and demonstrated a favourable prognostic significance of high AHRR and low SFRP2 expression.